공시 • Mar 27
Neutrogena, Aveeno And Rogaine Part of the Kenvue portfolio Debut New Dermatology Research And Clinical Skincare Innovations
Neutrogena, Aveeno and Rogaine, part of the Kenvue portfolio, will debut new science, innovative products and 20 research abstracts supporting continued advances in skin health and beauty, while addressing top consumer concerns at the 2026 American Academy of Dermatology (AAD) Annual Meeting in Denver, Colorado, March 27–31. Neutrogena, Aveeno and Rogaine are committed to developing safe, effective, science backed solutions that meaningfully improve skin and hair health. At AAD 2026, presentations and onsite experiences will highlight advances addressing concerns from fine lines to daily sun protection. In collaboration with industry experts, the brands will share clinical research that evaluates current formulas and introduces new solutions designed to hydrate skin, support healthy aging, maintain hair health and strengthen protection against UV exposure. In addition to sharing new data, the brands will host theater talks and panels with key opinion leaders on compelling topics in dermatologic health and host a dedicated Resident's Corner. Key areas of focus the company will spotlight include: Nearly eight in 10 people say they use skincare for prevention and to support healthy aging, showing that consumers increasingly want products that help them feel confident and in control of their skin as it evolves. New Neutrogena innovations are designed to support this desire by helping maintain healthy skin at every age. Tested in cellular and tissue models, Neutrogena Collagen Bank Vitamin C Serum, a dual-action 15% vitamin C serum preserved skin barrier strength. Focusing on deep hydration for clinically sensitive skin, Neutrogena and Aveeno are a healthcare provider's perfect hydration partners for patient treatment plans. A panel titled Moisture in Motion: How Hydro Boost Enhances Treatment Journeys From Acne to Procedures will dive into the pre- and post-procedural clincal results of the Neutrogena Hydro Boost line, showing how it helps reduce the appearance of redness, optimizing smoothness and radiance in people before and after fraxel laser, microneedling and chemical peel treatments. Formulated with Triple Oat and Glycerin, Aveeno Skin Relief Healing Ointment increases skin hydration levels and improved surface roughness. Compared to a leading petrolatum ointment, Aveeno Skin Relief Healing Ointment provided superiority in moisturization. When used on human skin tissue being stressed by UV radiation, the ingredients in Aveeno Calm & Restore, oat flour and oat beta glucan, synergistically upregulate production of hyaluronic acid in human fibroblasts and protect against UV induced degradation of hyaluronic acid in skin explants to hydrate the skin. Since acne solutions remain a top concern for healthcare providers and consumers, with acne being the #1 skin concern for adults under 40, Neutrogena developed an acne line with the skin barrier in mind. A new study found that the Neutrogena Clear Pore Cleanser/Mask offers an effective level of benzoyl peroxide (3.5%) for daily management of acne, improving skin's appearance and leaving it feeling soft and smooth. Providers know the best sunscreen is the one their patients will use every day, and Neutrogena leads in the formulation and efficacy of sun protection. Yet, according to the New View of Care Report by Kenvue, although most consumers recognize the preventative benefits of sun care, only 17% rank it among their top 3 essential personal care steps. Promising data will be shared about products containing bis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT), a broad-spectrum UV filter used in sunscreens abroad that is now being considered for approval in the United States. While BEMT's SPF rating varied by formulation, researchers concluded that carefully designing sunscreens can maximize BEMT's full UV-protective capacity. Gaps in protection against sun damage were revealed in several studies — including two using Neutrogena Helioplex 360 that investigated the damage caused by boundary region light (wavelengths 380-430 nm) which are not covered by most current sunscreens. In a survey of sun protection behaviors, 5,000 respondents disclosed underuse of UV protection, with habits varying across generations and income groups. A panel titled Everything Under the Sun: Understanding the Future of Sun Protection will highlight the Neutrogena brand's efforts to unite stakeholders and educate on the need to continue innovating in sun care. The panel will focus on the benefits of BEMT and create an opportunity for dermatologists to encourage patients to use sunscreen consistently and effectively. For the first time, a Resident's Corner will deliver accessible, over-the counter formulation-science education to support the next generation of dermatologists. In collaboration with Boards University, Neutrogena is expanding high value clinical learnings and strengthening the community among dermatology trainees. Residents can win exclusive giveaways to support their growth in dermatology practice and apply for scholarship opportunities to attend George Washington University's second annual Lab to Label conference.